1. Home
  2. NGNE vs TSBK Comparison

NGNE vs TSBK Comparison

Compare NGNE & TSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$28.86

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Logo Timberland Bancorp Inc.

TSBK

Timberland Bancorp Inc.

HOLD

Current Price

$41.98

Market Cap

317.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
TSBK
Founded
2003
1915
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
317.7M
IPO Year
2014
1997

Fundamental Metrics

Financial Performance
Metric
NGNE
TSBK
Price
$28.86
$41.98
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$63.57
N/A
AVG Volume (30 Days)
116.6K
19.2K
Earning Date
05-08-2026
04-28-2026
Dividend Yield
N/A
2.87%
EPS Growth
0.93
21.93
EPS
N/A
1.94
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.05
Revenue Growth
N/A
N/A
52 Week Low
$14.65
$29.96
52 Week High
$37.27
$43.55

Technical Indicators

Market Signals
Indicator
NGNE
TSBK
Relative Strength Index (RSI) 55.97 62.43
Support Level $28.37 $37.50
Resistance Level $28.93 $43.55
Average True Range (ATR) 1.78 1.02
MACD -0.01 0.23
Stochastic Oscillator 80.48 88.09

Price Performance

Historical Comparison
NGNE
TSBK

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

Share on Social Networks: